Accumulating evidence from studies with xenografted mice suggest that the MM-initiating cells are confined within a small CD19+CD138- subset differing from the CD20-CD138+ malignant bulk unable to engraft in NOD/SCID mouse model [22-24]. Here, CD19 is linked to Miyoshi myopathy.